Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
2.
J Bodyw Mov Ther ; 32: 218-227, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-36180153

RESUMO

BACKGROUND: Therapeutic taping may be a useful modality in relieving pain, improving strength, and restoring the function of patients with De Quervain's Disease (DQD). Evidence on the effectiveness of therapeutic taping for DQD patients in mitigating its clinical signs and symptoms is not established. However, reviews report Kinesio Taping effects on musculoskeletal pains not specific to DQD. METHODS: The study followed the guideline statement of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Two researchers (RD and SN) searched the electronic databases and hand-searched for relevant journals. The relevant articles were selected using keywords found in titles and abstracts and, consequently, full-text manuscripts. A third researcher (VCDIII) resolved the disagreements between the two researchers. They used Review Manager 5.4 for risk of bias assessment and meta-analysis. Data were pooled to determine the therapeutic taping's overall effect. Heterogeneity was assessed by Higgin's (I2) statistic. The random-effects model was used if heterogeneity was high (>60%). The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) Approach determined the certainty of evidence. RESULTS: Seven high-risk of bias clinical-controlled trials comprising 241 participants were included in the meta-analysis. The reported outcome measures were the Visual Analogue Scale (VAS) for pain, Patient-Rated Wrist/Hand Examination for Function and Power, and precision grip strength using a hand-held dynamometer and pinch gauge. Therapeutic taping did not improve the pain, power grip, grip strength, and function of participants with DQD (p > 0.05). Therapeutic taping compared to other physical therapy interventions did not reduce the VAS scores of 241 participants with DQD [SMD (95% CI) = -1.08 (-2.55,0.39), p = 0.15]. Kinesio taping with low-level laser therapy compared to ultrasound and exercise did not improve the function of 60 participants with DQD [SMD (95% CI) = 0.56 (-4.71,3.60), p = 0.79]. Therapeutic taping compared to ultrasound and Mulligan Pain Releasing Phenomenon did not improve the power grip strength of 50 participants with DQD [SMD (95% CI) = 1.24 (-0.83,3.31), p = 0.24]. Therapeutic taping was not better than phonophoresis in improving the precision grip strength of 50 participants with DQD [SMD (95% CI) = 0.43 (-1.95,2.80), p = 0.72]. CONCLUSIONS: There is insufficient evidence to recommend the use of therapeutic taping in treating patients with DQD. Therapeutic taping was no better than other treatment modalities in mitigating the clinical signs and symptoms of DQD (p > 0.05). Therapeutic taping did not affect wrist pain, handgrip, pincer strength, and function of participants with DQD (p > 0.05).


Assuntos
Fita Atlética , Doença de De Quervain , Dor Musculoesquelética , Doença de De Quervain/terapia , Força da Mão , Humanos , Medição da Dor
3.
JAMA ; 327(24): 2434-2445, 2022 06 28.
Artigo em Inglês | MEDLINE | ID: mdl-35762992

RESUMO

Importance: Carpal tunnel syndrome, trigger finger, de Quervain tenosynovitis, and basilar (carpometacarpal) joint arthritis of the thumb can be associated with significant disability. Observations: Carpal tunnel syndrome is characterized by numbness and tingling in the thumb and the index, middle, and radial ring fingers and by weakness of thumb opposition when severe. It is more common in women and people who are obese, have diabetes, and work in occupations involving use of keyboards, computer mouse, heavy machinery, or vibrating manual tools. The Durkan physical examination maneuver, consisting of firm digital pressure across the carpal tunnel to reproduce symptoms, is 64% sensitive and 83% specific for carpal tunnel syndrome. People with suspected proximal compression or other compressive neuropathies should undergo electrodiagnostic testing, which is approximately more than 80% sensitive and 95% specific for carpal tunnel syndrome. Splinting or steroid injection may temporarily relieve symptoms. Patients who do not respond to conservative therapies may undergo open or endoscopic carpal tunnel release for definitive treatment. Trigger finger, which involves abnormal resistance to smooth flexion and extension ("triggering") of the affected finger, affects up to 20% of adults with diabetes and approximately 2% of the general population. Steroid injection is the first-line therapy but is less efficacious in people with insulin-dependent diabetes. People with diabetes and those with recurrent symptoms may benefit from early surgical release. de Quervain tenosynovitis, consisting of swelling of the extensor tendons at the wrist, is more common in women than in men. People with frequent mobile phone use are at increased risk. The median age of onset is 40 to 59 years. Steroid injections relieve symptoms in approximately 72% of patients, particularly when combined with immobilization. People with recurrent symptoms may be considered for surgical release of the first dorsal extensor compartment. Thumb carpometacarpal joint arthritis affects approximately 33% of postmenopausal women, according to radiographic evidence of carpometacarpal arthritis. Approximately 20% of patients require treatment for pain and disability. Nonsurgical interventions (immobilization, steroid injection, and pain medication) relieve pain but do not alter disease progression. Surgery may be appropriate for patients unresponsive to conservative treatments. Conclusions and Relevance: Carpal tunnel syndrome, trigger finger, de Quervain tenosynovitis, and thumb carpometacarpal joint arthritis can be associated with significant disability. First-line treatment for each condition consists of steroid injection, immobilization, or both. For patients who do not respond to noninvasive therapy or for progressive disease despite conservative therapy, surgical treatment is safe and effective.


Assuntos
Artrite , Síndrome do Túnel Carpal , Articulações Carpometacarpais , Doença de De Quervain , Tenossinovite , Dedo em Gatilho , Adulto , Artrite/diagnóstico , Artrite/etiologia , Artrite/terapia , Síndrome do Túnel Carpal/diagnóstico , Síndrome do Túnel Carpal/etiologia , Síndrome do Túnel Carpal/terapia , Doença de De Quervain/diagnóstico , Doença de De Quervain/etiologia , Doença de De Quervain/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor Musculoesquelética/tratamento farmacológico , Dor Musculoesquelética/etiologia , Dor/tratamento farmacológico , Dor/etiologia , Contenções , Esteroides/uso terapêutico , Tenossinovite/diagnóstico , Tenossinovite/etiologia , Tenossinovite/terapia , Dedo em Gatilho/diagnóstico , Dedo em Gatilho/etiologia , Dedo em Gatilho/terapia
4.
J Hand Surg Am ; 47(3): 284.e1-284.e6, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-34147317

RESUMO

PURPOSE: We hypothesized that repeat injections are associated with a decreased rate of success and that the success rate of injections correlates with patient comorbidities. METHODS: Using a commercially available insurance database, patients diagnosed with De Quervain tenosynovitis were identified using International Classification of Diseases, Ninth Revision and Tenth Revision codes and stratified by therapeutic interventions, including therapy, injections, and surgery, as well as comorbidities. Injection failure was defined as a patient receiving a repeat injection or subsequent surgical management. Success was defined as no further therapies identified after an intervention. RESULTS: From 2007 to 2017, 33,420 patients with a primary diagnosis of De Quervain tenosynovitis were identified. Women represented 77.5% (25,908) of the total and were 2.6 times more likely to be diagnosed than men. Black patients were more likely to be diagnosed than White patients. Black and White women were found to have the highest incidence (relative risk 3.4 and 2.3, respectively, compared with White men). Age was also significantly correlated with an increased risk of diagnosis of the condition, with a peak incidence at the age of 40-59 years (relative risk, 10.6). Diabetes, rheumatoid arthritis, lupus, and hypothyroidism were associated with an increased risk of diagnosis. Overall, 53.3% of the patients were treated with injections, 11.6% underwent surgery, and 5.2% underwent therapy. Treatment with a single injection was successful in 71.9% of the patients, with 19.7% receiving a repeat injection and 8.4% treated with surgery. The overall success rate of subsequent injections was 66.3% for the second injection and 60.5% for the third. The initial injection had a higher rate of success in diabetics than in nondiabetics; however, the difference (2%) was not clinically relevant. CONCLUSIONS: Although the success rate for the treatment of De Quervains tenosynovitis decreases with multiple injections, repeat injections have a high rate of success and are a viable clinical option. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic II.


Assuntos
Doença de De Quervain , Tenossinovite , Adulto , Bases de Dados Factuais , Doença de De Quervain/diagnóstico , Doença de De Quervain/epidemiologia , Doença de De Quervain/terapia , Feminino , Humanos , Incidência , Injeções , Masculino , Pessoa de Meia-Idade , Tenossinovite/epidemiologia , Tenossinovite/terapia
5.
Int J Biometeorol ; 65(8): 1391-1398, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33675398

RESUMO

Data on the efficacy of treatment modalities in De Quervain's tenosynovitis (DQT) is limited. Paraffin therapy is routinely used in treating hand osteoarthritis and neuropathies. However, there are not enough studies investigating paraffin effectiveness. This study evaluates the effectiveness of paraffin bath therapy on pain, functional status, muscle strength, and quality of life in patients with DQT. This prospective, single-blind, randomized, controlled study enrolled 51 DQT patients. Group 1 (n = 26) received paraffin bath + splint + exercise; Group 2 (n = 25) received splint + exercise therapy. Pain, handgrip strength, thumb palmar pinch strength, functional status, and quality of life were evaluated. Both treatment combinations improved pain, grip strength, palmar pinch strength of the thumb, functional status, and quality of life. The paraffin group provided more effective pain control than the paraffin-free group and was more effective in improving functional status, handgrip strength, and quality of life (p < 0.05). Apparently, adding paraffin therapy to the combination of the splint and therapeutic exercise positively affects the patient's treatment outcomes. For this reason, paraffin therapy should be included in the conservative treatment combinations in DQT.


Assuntos
Doença de De Quervain , Tenossinovite , Doença de De Quervain/terapia , Força da Mão , Humanos , Parafina , Estudos Prospectivos , Qualidade de Vida , Método Simples-Cego
6.
Medicine (Baltimore) ; 99(49): e23483, 2020 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-33285752

RESUMO

BACKGROUND: De Quervain disease (DQD) is a common clinical disease. As a strainingdisease, DQD is more common in women who frequently engage in manual operations. The main clinical symptoms are local pain and dysfunction. Many clinical studies have reported that moxibustion has a good effect on the treatment of DQD, but there is no relevant systematic review. So the purpose of this study is to evaluate the effectiveness and safety of moxibustion in treating DQD. METHODS: The following 8 electronic databases will be searched, including PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Web of Science, Chinese Scientific Journal Database (VIP), Wanfang Database, and Chinese Biomedical Literatures Database (CBM) from their inception to 1 October 2020 without any restrictions. Researchers retrieve the literature and extracted the data, evaluation of research methods, quality of literature. The outcomes will include a visual analogue scale, Finkelsteins, resisted thumb extension, total effective rate, incidence of any adverse events. We use the Cochrane Risk of a bias assessment tool to evaluate methodological qualities. Data synthesis will be completed by RevMan 5.3.0. RESULTS: We will show the results of this study in a peer-reviewed journal. CONCLUSIONS: This meta-analysis will provide reliable evidence for moxibustion treatment of DQD. INPLASY REGISTRATION NUMBER: INPLASY2020100111.


Assuntos
Doença de De Quervain/terapia , Moxibustão/métodos , Doença de De Quervain/fisiopatologia , Humanos , Metanálise como Assunto , Ensaios Clínicos Controlados não Aleatórios como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Revisões Sistemáticas como Assunto , Polegar/fisiopatologia , Resultado do Tratamento , Escala Visual Analógica
8.
Plast Reconstr Surg ; 146(1): 105-126, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32590652

RESUMO

BACKGROUND: Nonsurgical management of de Quervain disease relies mainly on the use of oral nonsteroidal antiinflammatory drug administration, splint therapy, and corticosteroid injections. Although the latter is most effective, with documented success rates of 61 to 83 percent, there exists no clear consensus pertaining to conservative treatment protocols conferring the best outcomes. This article reports on all present conservative treatment modalities in use for the management of de Quervain disease and highlights specific treatment- and patient-related factors associated with the best outcomes. METHODS: A systematic search was performed using the PubMed database using appropriate search terms; two independent reviewers evaluated retrieved articles using strict inclusion and exclusion criteria. RESULTS: A total of 66 articles met the inclusion criteria for review, consisting of 22 articles reporting on outcomes following a single conservative treatment modality, eight articles reporting on combined treatment approaches, 13 articles directly comparing different conservative treatment regimens, and 23 case reports. CONCLUSIONS: A multimodal approach using splint therapy and corticosteroid injections appears to be more beneficial than either used in isolation. Although there exists some evidence showing that multipoint injection techniques and multiple injections before surgical referral may provide benefit over a single point injection technique and a single injection before surgery, corticosteroid use is not benign and should thus be performed with caution. Ultrasound was proven valuable in the visualization of an intercompartmental septum, and ultrasound-guided injections were shown to both be more accurate and confer better outcomes. Several prior and concurrent medical conditions may affect conservative treatment outcome. A Level I to II evidence-based treatment protocol is recommended for the optimal nonsurgical management of de Quervain disease.


Assuntos
Tratamento Conservador/métodos , Doença de De Quervain/terapia , Corticosteroides/uso terapêutico , Algoritmos , Anti-Inflamatórios , Terapia Combinada/métodos , Humanos , Contenções
9.
Orv Hetil ; 161(11): 419-424, 2020 Mar.
Artigo em Húngaro | MEDLINE | ID: mdl-32148092

RESUMO

Introduction: De Quervain's tendinopathy affects the region of the wrist and the hand. Thumb motion becomes painful. This illness is caused by a degenerative process rather than inflammation. Primary treatment methods are splinting, taking non-steroid anti-inflammatory drugs and different physical therapeutic modalities, administration of a steroid injection into the tendon sheath or surgical release of the tendon sheath may be performed. Aim: The aim of the present study was to investigate whether conservative treatment complemented by eccentric training could provide an adequate alternative to the currently accepted treatment options. Method: The eccentric training lasted for 8 weeks (if necessary for 12 weeks). Following the introduction to exercises, patients (n = 9) repeated the training several times a day, which was controlled during weekly meetings. At the 1st, 8th and 12th meetings, inspection and the following measurements were performed: range of motion, muscle strength, evaluation and number of painful regions including the completion of patient questionnaires. Data were analysed with paired samples t-tests and repeated measures ANOVA. IBM SPSS Statistics 25.0 and Microsoft Office Excel Professional Plus 2016 programs were used. Results were regarded significant at level of p<0.05. Results: Significant improvements were found in the intensity of pain (Numeric Pain Rating Scale p = 0.005, n = 9) and in the functionality of the hand and wrist (Quick Disabilities of the Arm, Shoulder and Hand questionnaire part 1. p<0.001, part 2. p<0.001, Patient-Rated Wrist Evaluation questionnaire p<0.001; n = 9). Conclusion: With careful patient selection, conservative treatment complemented by eccentric training could be an alternative to current treatment options. Orv Hetil. 2020; 161(11): 419-424.


Assuntos
Tratamento Conservador , Doença de De Quervain/terapia , Modalidades de Fisioterapia , Tendinopatia/terapia , Doença de De Quervain/diagnóstico , Humanos , Dor , Medição da Dor , Tendinopatia/diagnóstico , Resultado do Tratamento
10.
Eur Radiol ; 30(4): 2220-2230, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31844963

RESUMO

BACKGROUND: Although image-guided interventional procedures of the elbow and wrist are routinely performed, there is poor evidence in the literature concerning such treatments. Our aim was to perform a Delphi-based consensus on published evidence on image-guided interventional procedures around the elbow and wrist and provide clinical indications on this topic. METHODS: A board of 45 experts in image-guided interventional musculoskeletal procedures from the European Society of Musculoskeletal Radiology were involved in this Delphi-based consensus study. All panelists reviewed and scored published papers on image-guided interventional procedures around the elbow and wrist updated to September 2018 according to the Oxford Centre for Evidence-based Medicine levels of evidence. Consensus on statements drafted by the panelists about clinical indications was considered as "strong" when more than 95% of panelists agreed and as "broad" if more than 80% agreed. RESULTS: Eighteen statements were drafted, 12 about tendon procedures and 6 about intra-articular procedures. Only statement #15 reached the highest level of evidence (ultrasound-guided steroid wrist injections result in greater pain reduction and greater likelihood of attaining clinically important improvement). Seventeen statements received strong consensus (94%), while one received broad consensus (6%). CONCLUSIONS: There is still poor evidence in published papers on image-guided interventional procedures around the elbow and wrist. A strong consensus has been achieved in 17/18 (94%) statements provided by the panel on clinical indications. Large prospective randomized trials are needed to better define the role of these procedures in clinical practice. KEY POINTS: • The panel provided 18 evidence-based statements on clinical indications of image-guided interventional procedures around the elbow and wrist. • Only statement #15 reached the highest level of evidence: ultrasound-guided steroid wrist injections result in greater pain reduction and greater likelihood of attaining clinically important improvement. • Seventeen statements received strong consensus (94%), while broad consensus was obtained by 1 statement (6%).


Assuntos
Doença de De Quervain/terapia , Tendinopatia do Cotovelo/terapia , Radiografia Intervencionista , Dedo em Gatilho/terapia , Ultrassonografia de Intervenção , Técnica Delfos , Agulhamento Seco , Articulação do Cotovelo , Fluoroscopia , Glucocorticoides/administração & dosagem , Humanos , Ácido Hialurônico/administração & dosagem , Injeções , Injeções Intra-Articulares , Plasma Rico em Plaquetas , Estudos Prospectivos , Radiografia , Tenotomia , Viscossuplementos/administração & dosagem , Articulação do Punho
11.
Medicine (Baltimore) ; 98(46): e17765, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31725617

RESUMO

BACKGROUND: De Quervain disease (dQD) is a painful condition of the wrist that affects patients' quality of life and work ability. Acupotomy has been widely used in the treatment of dQD. It has been reported in many articles that acupotomy can improve the clinical symptoms of dQD. However, the efficacy has not been evaluated scientifically and systematically. The aim of this systematic review protocol is to evaluate the efficacy and safety of acupotomy treatment compared with local steroid injection in patients with de Quervain disease. METHODS: Relevant randomized controlled trials will be identified by searching 9 databases (PubMed, EMBASE, Cochrane Library, Chinese literature databases, the Chinese Biomedical Literature Database [CBM], China National Knowledge Infrastructure [CNKI], SinoMed, Technology Journal [VIP], and the Wanfang Database). Randomized controlled trials (RCTs) of Acupotomy for dQD patients will be identified independently by 2 reviewers by searching the databases from inception to October 2018. Clinical effects will be evaluated as the primary outcome. The VAS (visual analog scale) score will be assessed as a secondary outcome. RevMan V.5.3 will be used to perform a fixed effect meta-analysis, and the evidence level will be evaluated by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods. Continuous outcomes will be presented as the mean differences or standard mean differences, while dichotomous data will be expressed as relative risks. RESULTS: This study will evaluate the effectiveness and safety of acupotomy in the treatment of de Quervain disease in RCTs with high-quality VAS and RM. CONCLUSION: This systematic review will provide evidence to judge whether acupotomy is an effective intervention for patients with de Quervain disease. PROSPERO REGISTRATION NUMBER: CRD42018108786.


Assuntos
Terapia por Acupuntura/estatística & dados numéricos , Doença de De Quervain/terapia , Esteroides/administração & dosagem , Terapia por Acupuntura/métodos , Humanos , Injeções Intra-Articulares , Medição da Dor , Ensaios Clínicos Controlados Aleatórios como Assunto , Recidiva , Projetos de Pesquisa , Revisões Sistemáticas como Assunto , Resultado do Tratamento , Articulação do Punho
13.
Arch. health invest ; 8(5): 245-250, maio 2019. tab
Artigo em Português | BBO - odontologia (Brasil) | ID: biblio-1026208

RESUMO

Introdução: A tenossinovite estenosante de De Quervain, doença inflamatória mais comum do punho, de maior prevalência no sexo feminino e na faixa etária de 30 a 50 anos, caracteriza-se pelo envolvimento da bainha sinovial do primeiro compartimento extensor do punho, que inclui os tendões abdutor longo do polegar (ALP) e extensor curto do polegar (ECP). Apesar da etiologia indefinida, atribui-se caráter multifatorial como traumas, sobrecarga de exercícios repetitivos com punho e mão, alterações metabólicas, reumáticas e variações anatômicas, como a presença de dois ou mais tendões do ALP e ECP e septo no túnel osteofibroso. Dentre as alternativas terapêuticas encontra-se a infiltração com corticosteroides. Material e Método: Foi avaliado o resultado terapêutico em 15 pacientes submetidos à infiltração local de corticosteroide através dos questionários DASH, PRWE e Escala Visual da Dor. Resultados: observou-se melhora significativa dos pacientes avaliados. Conclusão: o tratamento com corticosteroides é eficaz e seguro(AU)


Introduction: Quervain's tenosynovitis, the most common inflammatory wrist disease, most prevalent in females and in the age group of 30 to 50 years, is characterized by the involvement of the synovial sheath of the first extensor compartment of the wrist, which includes the thumb long abductor tendons (ALP) and short thumb extensor (ECP) tendons. Despite the undefined etiology, multifactorial character is attributed as trauma, overload of repetitive exercises with wrist and hand, metabolic, rheumatic alterations and anatomical variations, such as the presence of two or more ALP and ECP tendons and osteofibrosal tunnel septum. Among the therapeutic alternatives is infiltration with corticosteroids. Material and Method: The therapeutic outcome was evaluated in 15 patients who underwent local corticosteroid infiltration using the DASH and PRWE questionnaires and Visual Analogue Scale. Results: Significant improvement was observed in the evaluated patients. Conclusion: Corticosteroid treatment is effective and safe(AU)


Introducción: la tenosinovitis de De Quervain, la enfermedad inflamatoria de la muñeca más común, más prevalente en mujeres y en el grupo de edad de 30 a 50 años, se caracteriza por la afectación de la vaina sinovial del primer compartimento extensor de la muñeca, que incluye el tendones abductores largos del pulgar (ALP) y tendones extensores del pulgar cortos (ECP). A pesar de la etiología indefinida, el carácter multifactorial se atribuye a trauma, sobrecarga de ejercicios repetitivos con muñeca y mano, alteraciones metabólicas, reumáticas y variaciones anatómicas, como la presencia de dos o más tendones ALP y ECP y tabique osteofibrosal. Entre las alternativas terapéuticas se encuentra la infiltración con corticosteroides. Material y método: El resultado terapéutico se evaluó en 15 pacientes que se sometieron a infiltración local de corticosteroides utilizando los cuestionarios DASH y PRWE y escala visual analógica del dolor. Resultados: se observó una mejoría significativa en los pacientes evaluados. Conclusión: el tratamiento con corticosteroides es efectivo y seguro(AU)


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Corticosteroides , Doença de De Quervain , Doença de De Quervain/tratamento farmacológico , Tenossinovite , Doença de De Quervain/terapia
14.
Eur Radiol ; 28(9): 3977-3985, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29619521

RESUMO

PURPOSE: To evaluate the efficacy of ultrasonography-guided percutaneous treatment of de Quervain tenosynovitis with the combination of a corticosteroid injection and release of the retinaculum of the first extensor compartment tendons with a 21-gauge needle. MATERIALS AND METHODS: The first part of our study consisted of ten procedures on cadaver wrists followed by dissection to analyse the effectiveness of the retinaculum release and detect any collateral damage. The second part was a prospective clinical study of 35 procedures. Outcomes were evaluated through a 6-month clinical follow-up and telephone interview at the end of the study. The following parameters were monitored over time: pain level on a visual analogue scale, the QuickDASH and the PRWE. Patient satisfaction questionnaires were also administered. RESULTS: No complications were found during the cadaver study. However, the release was confirmed as 'partial' in all wrists. In the clinical portion of this study, significant improvement was observed in 91.4 % of cases (32/35) within 1 month and the results were stable until the end of the study; all of these patients avoided surgery. The release procedure failed in three patients who eventually required surgical treatment. CONCLUSION: US-guided partial release and simultaneous corticosteroid injection for treatment of de Quervain's disease using a 21-gauge needle is feasible in current practice, with minimal complications. KEY POINTS: • Ultrasound-guided treatment of de Quervain's disease is feasible with a 21G needle. • There was notable regression of clinical signs in 91.4 % of cases. • The procedure is very safe, no iatrogenic neurovascular or tendinous injuries occurred. • Our procedure requires only one session and 3 days away from work.


Assuntos
Doença de De Quervain/diagnóstico por imagem , Doença de De Quervain/terapia , Injeções Intralesionais , Ultrassonografia de Intervenção , Corticosteroides/uso terapêutico , Adulto , Idoso , Cadáver , Doença de De Quervain/tratamento farmacológico , Feminino , Antebraço , Humanos , Injeções Intralesionais/instrumentação , Masculino , Pessoa de Meia-Idade , Agulhas , Medição da Dor , Avaliação de Resultados da Assistência ao Paciente , Estudos Prospectivos , Tendões
15.
Arch Phys Med Rehabil ; 99(8): 1635-1649.e21, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-28860097

RESUMO

OBJECTIVES: To provide an evidence-based overview of the effectiveness of conservative and (post)surgical interventions for trigger finger, Dupuytren disease, and De Quervain disease. DATA SOURCES: Cochrane Library, Physiotherapy Evidence Database, PubMed, Embase, and CINAHL were searched to identify relevant systematic reviews and randomized controlled trials (RCTs). DATA SELECTION: Two reviewers independently applied the inclusion criteria to select potential studies. DATA EXTRACTION: Two reviewers independently extracted the data and assessed the methodologic quality. DATA SYNTHESIS: A best-evidence synthesis was performed to summarize the results. Two reviews (trigger finger and De Quervain disease) and 37 randomized controlled trials (RCTs) (trigger finger: n=8; Dupuytren disease: n=14, and De Quervain disease: n=15) were included. The trials reported on oral medication (Dupuytren disease), physiotherapy (De Quervain disease), injections and surgical treatment (trigger finger, Dupuytren disease, and De Quervain disease), and other conservative (De Qervain disease) and postsurgical treatment (Dupuytren disease). Moderate evidence was found for the effect of corticosteroid injection on the very short term for trigger finger, De Quervain disease, and for injections with collagenase (30d) when looking at all joints, and no evidence was found when looking at the PIP joint for Dupuytren disease. A thumb splint as additive to a corticosteroid injection seems to be effective (moderate evidence) for De Quervain disease (short term and midterm). For Dupuytren disease, use of a corticosteroid injection within a percutaneous needle aponeurotomy in the midterm and tamoxifen versus a placebo before or after a fasciectomy seems to promising (moderate evidence). We also found moderate evidence for splinting after Dupuytren surgery in the short term. CONCLUSIONS: In recent years, more and more RCTs have been conducted to study treatment of the aforementioned hand disorders. However, more high-quality RCTs are still needed to further stimulate evidence-based practice for patients with trigger finger, Dupuytren disease, and De Quervain disease.


Assuntos
Tratamento Conservador/estatística & dados numéricos , Doença de De Quervain/terapia , Contratura de Dupuytren/terapia , Procedimentos Ortopédicos/estatística & dados numéricos , Modalidades de Fisioterapia/estatística & dados numéricos , Dedo em Gatilho/terapia , Humanos , Período Pós-Operatório , Resultado do Tratamento
16.
Medicine (Baltimore) ; 96(35): e7875, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28858099

RESUMO

The presence of a septum in the first extensor compartment is closely associated with the pathophysiology of de Quervain disease, and affects the efficacy of corticosteroid injection and surgical release. This study aimed to examine the incidence and length of the first extensor compartment septum.Forty sides of the wrists in 20 cadavers were used. The presence of a septum in the first extensor compartment was examined. The septum length was recorded with the radial styloid process as the reference point.The anatomical variations of the first extensor compartment were classified into 3 types. Type I compartment was found in 7 sides in males (29.2%) versus 6 sides in females (37.5%, P = .733), type II was found in 6 sides in males (25%) versus 1 side in females (6.25%, P = .21), and type III was found in 11 sides in males (45.8%) versus 9 sides in females (56.25%, P = .56). There was no significant difference in the septum length between males and females (5.3 ±â€Š2.3 vs 4.8 ±â€Š1.1 mm, P = .54).The incidence of a septum in the first extensor compartment is approximately 50%. The mean septum length is 5 mm. Injection at 5 mm proximal to the radial styloid process has a great chance of delivering the steroids into both subcompartments. Exposure to 5 mm proximal to the radial styloid process can avoid the overlook of subcompartment and achieve adequate decompression of the first extensor compartment.


Assuntos
Doença de De Quervain/patologia , Tendões/anatomia & histologia , Articulação do Punho/anatomia & histologia , Corticosteroides/administração & dosagem , Cadáver , Doença de De Quervain/terapia , Descompressão Cirúrgica/métodos , Feminino , Humanos , Masculino
18.
J Back Musculoskelet Rehabil ; 30(4): 691-697, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28035912

RESUMO

BACKGROUND: The management of De Quervain's disease is determined more by Intuition than scientific data. The choice of first line conservative option for the management of De Quervain's disease is still a topic of debate. AIM: To evaluate the effectiveness of therapeutic ultrasound with or without spica splint in the management of De Quervain's disease (DQD). DESIGN: Randomized controlled trial (RCT). SETTING: Outpatient department of Al-Nafees Medical College Hospital, Islamabad, Pakistan. POPULATION: Thirty patients who had the history of the De Quervain's disease for at least 6 months were enrolled in the study. The ages of the patient were 30-50 year. The population included housewives, maids, painters, and teachers. METHODS: Thirty patients were divided into two groups. The control group was treated with therapeutic ultrasound while in the experimental group thumb spica splitting was also added. The data was collected from the subjects through Quick Disabilities of the Arm, Shoulder and Hand questionnaire. The demographic data was presented in the form of tables. Intervention-induced changes within the groups were investigated using paired sample t-test while independent sample t-test was used to compare the two groups. RESULTS: Significant changes within both groups (p ≤ 0.05) were observed as a result of intervention. Additionally, significant differences in some instrument items were found between experimental and control group (p ≤ 0.05) after intervention. However, some items did not demonstrate significant changes in both groups likely because there was no effect of De Quervain's disease on those items before the intervention. CONCLUSION: The results showed that the use of therapeutic ultrasound and spica splint together is more effective than using therapeutic ultrasound alone in the conservative management of De Quervain's disease. CLINICAL REHABILITATION IMPACT: This study provides evidence to the relevant clinicians and professionals on the utility of therapeutic ultrasound combined with thumb spica splint in the conservative management of DQD.


Assuntos
Doença de De Quervain/terapia , Contenções/estatística & dados numéricos , Terapia por Ultrassom , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polegar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA